Olema Pharmaceuticals Inc...

NASDAQ: OLMA · Real-Time Price · USD
5.52
0.26 (4.94%)
At close: Aug 15, 2025, 3:59 PM
5.54
0.36%
After-hours: Aug 15, 2025, 06:03 PM EDT

Olema Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
139.48M 68.54M 23.7M 287.25M
Short-Term Investments
294.61M 193.27M 180.72M 273.44M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
10.51M 7.17M 2.77M 3.98M
Receivables
2.12M 673K 319K n/a
Inventory
n/a n/a -319K -353K
Other Current Assets
366K 1.68M 1.5M n/a
Total Current Assets
438.47M 266.51M 208.9M 287.25M
Property-Plant & Equipment
1.31M 3.26M 3.98M 4.72M
Goodwill & Intangibles
683K n/a n/a n/a
Total Long-Term Assets
12.51M 10.43M 6.75M 8.7M
Total Assets
450.98M 276.94M 215.65M 295.94M
Account Payables
4.46M 2.7M 374K 23K
Deferred Revenue
n/a n/a n/a 7.69M
Short-Term Debt
1.17M n/a n/a 931K
Other Current Liabilities
-1.17M 5.46M 68K 2.09M
Total Current Liabilities
41.76M 21.62M 16.55M 9.02M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
257K 1.43M 1.55M 2.36M
Total Liabilities
42.02M 23.05M 18.1M 11.38M
Total Debt
1.43M 2.42M 2.56M 3.29M
Common Stock
6K 4K 3K 3K
Retained Earnings
-435.11M -305.63M -208.98M -104.19M
Comprehensive Income
143K 347K -1.81M -149K
Shareholders Equity
408.96M 253.9M 197.55M 284.57M
Total Investments
294.61M 193.27M 180.72M 273.44M